Investigación

Estudio de enfermedades por disfunción inmune en Pediatría (GEMDIP)

Buscador de publicaciones

Publicaciones

  • Claudia Solito, Hernández-García M, Arguedas Casamayor N, Pavón Ortiz A, Pino-Ramirez RM, Alsina L and Fernández de Sevilla-Estrach M.

    COVID-19 admissions: Trying to define the real impact of infection in hospitalized patients.

    anales de pediatria . 100(5): 342-351. Nº de citas: 1

    [doi:10.1016/j.anpede.2024.03.049]

  • Dadvand P, Gascon M, Bustamante M, Rivas I, Foraster M, Basagaña X, Cosín M, Eixarch E, Ferrer M, Gratacós E, Gómez Herrera L, Jimenez-Arenas P, Júlvez J, Morillas À, Nieuwenhuijsen MJ, Persavento C, Pujol J, Querol X, Sánchez García O, Vrijheid M, Llurba E, Gómez-Roig MD and Sunyer J.

    Cohort Profile: Barcelona Life Study Cohort (BiSC).

    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY . 53(3): . Nº de citas: 4

    [doi:10.1093/ije/dyae063]

  • Foeldvari I, Torok KS, Anton-Lopez J, Blakley M, Constantin T, Cutolo M, Denton CP, Fligelstone K, Hinrichs B, Li SC, Maillard S, Marrani E, Moinzadeh P, Orteu CH, Pain CE, Pauling JD, Pilkington C, Rosser F, Smith V and Furst DF.

    Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022

    EXPERT REVIEW OF CLINICAL IMMUNOLOGY . 20(4): 387-404. Nº de citas: 5

    [doi:10.1080/1744666X.2023.2298354]

  • Utpatel C, Zavaleta M, Rojas-Bolivar D, Mühlbach A, Picoy J, Portugal W, Esteve-Solé A, Alsina L, Miotto P, Bartholomeu DC, Sanchez J, Cuadros DF, Alarcon JO, Niemann S and Huaman MA.

    Prison as a driver of recent transmissions of multidrugresistant tuberculosis in Callao, Peru: a cross-sectional study

    LANCET REGIONAL HEALTH-AMERICAS . 31: 100674-100674. Nº de citas: 3

    [doi:10.1016/j.lana.2024.100674]

  • Clemente D, Núñez-Cuadros E, Camacho-Lovillo M, Calzada-Hernández J, Guillén-Martin S, Fernández-Silveira L, Lirola-Cruz MJ, Tagarro A, Alcobendas-Rueda RM, López López A, Satrustegi-Aritziturri M and Calvo C.

    Position statement on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies, part 3: precautions in situations of surgery, fever, and opportunistic infections

    EUROPEAN JOURNAL OF PEDIATRICS . 183(2): 915-927.

    [doi:10.1007/s00431-023-05295-4]

  • Staniek J, Kalina T, Andrieux G, Boerries M, Janowska I, Fuentes M, Díez P, Bakardjieva M, Stancikova J, Raabe J, Neumann J, Schwenk S, Arpesella L, Stuchly J, Benes V, García Valiente R, Fernández García J, Carsetti R, Piano Mortari E, Català-Temprano A, de la Calle O, Sogkas G, Neven B, Rieux-Laucat F, Magerus A, Neth O, Olbrich P, Voll RE, Alsina L, Allende LM, Gonzalez-Granado LI, Böhler C, Thiel J, Venhoff N, Lorenzetti R, Warnatz K, Unger S, Seidl M, Mielenz D, Schneider P, Ehl S, Rensing-Ehl A, Smulski CR and Rizzi M.

    Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells

    Science immunology . 9(91): . Nº de citas: 4

    [doi:10.1126/sciimmunol.adj5948]

  • Abad MR, Alerany C, Alsina L, Granados EL, Neth O, Poveda JL, Rivière JG, Rodríguez-Gallego C, Tutein Nolthenius JB, Figueiredo R, Labazuy SS and Gil A.

    Determining value in the treatment of activated PI3Kd syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders

    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT . 11: 124-130. Nº de citas: 1

    [doi:10.33393/grhta.2024.3041]

  • Kennedy-Batalla R, Acevedo D, Luo Y, Esteve-Solé A, Vlagea A, Correa-Rocha R, Seoane-Reula ME and Alsina L.

    Treg in inborn errors of immunity: gaps, knowns and future perspectives

    FRONTIERS IN IMMUNOLOGY . 14: 1278759-1278759. Nº de citas: 8

    [doi:10.3389/fimmu.2023.1278759]

  • Fischer M, Olbrich P, Hadjadj J, Aumann V, Bakhtiar S, Barlogis V, von Bismarck P, Markéta Bloomfield MP, Booth C, Buddingh EP, Cagdas D, Castelle M, Chan AY, Chandrakasan S, Chetty K, Cougoul P, Crickx E, Dara J, Deyà-Martinez A, Farmand S, Formankova R, Gennery AR, Gonzalez-Granado LI, Hagin D, Hanitsch LG, Hanzlikovà J, Hauck F, Ivorra-Cortés J, Kisand K, Kiykim A, Körholz J, Leahy TR, van Montfrans J, Nademi Z, Nelken B, Suhag Parikh MD, Plado S, Ramakers J, Redlich A, Rieux-Laucat F, Rivière JG, Rodina Y, Júnior PR, Salou S, Schuetz C, Shcherbina A, Slatter MA, Touzot F, Unal E, Lankester AC, Siobhan Burns, Seppänen MRJ, Neth O, Albert MH, Ehl S, Neven B and Speckmann C.

    JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study

    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY . 153(1): 275-28618. Nº de citas: 22

    [doi:10.1016/j.jaci.2023.10.018]

  • Foeldvari I, Torok KS, Klotsche J, Anton-Lopez J, Reis PC, Del Gado F, Denton C, Hinrichs B, Li SC, Pain C, Pilkington C, Cutolo M, Kasapcopur O, Khanna D, Ruperto N, Smith V and Furst DE.

    Proposed Response Parameters for Twelve-Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings.

    ARTHRITIS CARE & RESEARCH . 75(12): 2453-2462. Nº de citas: 3

    [doi:10.1002/acr.25171]